Prothena reported $639K in Interest Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Alnylam Pharmaceuticals ALNY:US USD 7.82M 5.92M
Biogen BIIB:US USD 23.9M 11.3M
BioMarin Pharmaceutical BMRN:US USD 5M 2.49M
Bluebird Bio BLUE:US USD 383K 209K
Exelixis EXEL:US USD 9.5M 4.74M
Intra Cellular Therapies ITCI:US USD 2.12M 802K
Nektar Therapeutics NKTR:US USD 2.05M 954K
Ultragenyx Pharmaceutical RARE:US USD 3.48M 2.58M
Vertex Pharmaceuticals VRTX:US USD 46.2M 35.4M
Vital Therapies VTL:US USD 230K 124K